These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 23089750

  • 21. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
    Otani S, Hiramatsu K, Hashinaga K, Komiya K, Umeki K, Kishi K, Kadota JI.
    J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
    [Abstract] [Full Text] [Related]

  • 22. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y, Nicolas T, Godard C, Plesiat P.
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [Abstract] [Full Text] [Related]

  • 23. Cyclic-di-GMP levels affect Pseudomonas aeruginosa fitness in the presence of imipenem.
    Nicastro GG, Kaihami GH, Pereira TO, Meireles DA, Groleau MC, Déziel E, Baldini RL.
    Environ Microbiol; 2014 May; 16(5):1321-33. PubMed ID: 24975931
    [Abstract] [Full Text] [Related]

  • 24. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y, Yu XH, Wang R, An MM, Liang BB.
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR, White A, Elborn JS, Tunney MM.
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [Abstract] [Full Text] [Related]

  • 30. [The assay of beta-lactamase activity in Pseudomonas aeruginosa biofilm].
    Gu X, Li S, Zhang Z.
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):585-8. PubMed ID: 11758236
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z, Satana D, Kayacan C, Can B, Gönüllü N, Küçükbasmacı O.
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [Abstract] [Full Text] [Related]

  • 33. Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.
    Humphries RM, Hindler JA, Wong-Beringer A, Miller SA.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993338
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.
    Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4469-74. PubMed ID: 21670181
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
    Bustamante CI, Drusano GL, Tatem BA, Standiford HC.
    Antimicrob Agents Chemother; 1984 Nov; 26(5):678-82. PubMed ID: 6440477
    [Abstract] [Full Text] [Related]

  • 39. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H, Sáenz Y, Nichols WW, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.